Tag:

Paclitaxel

Latest Headlines

Latest Headlines

Geron axes dozens of staffers after careening into another trial flop

John Scarlett's plan to reinvent Geron as a developer of new and exciting cancer drugs has slammed into a fresh debacle.

Celgene's Abraxane delivers in melanoma study

Will Abraxane join the new gang of melanoma fighters?

Geron in meltdown as lead cancer drug crumbles in Phase II

Just 10 months after new Geron CEO John Scarlett dumped a decade's worth of stem cell work in favor of a special focus on cancer drugs, the biotech has written off a pair of lead drug studies after tracking discouraging progression-free survival data in Phase II.

Cephalon paying $10M in cancer tech deal

Cephalon is paying out $10 million to acquire the IP rights to Acusphere's Hydrophobic Drug Delivery

Avanti launches bionano company

Avanti Therapeutics launched a new bionanotechnology company for targeted drug delivery called Chikujee Therapeutics. Chikujee will use Avanti's drug delivery technology to enhance the performance of

ALSO NOTED: Phyton cuts staff; Alzheimer's: A new indication for Enbrel?; and much more...

> According to research released today, the anti-rheumatoid arthritis med Enbrel has shown an amazing ability to rehabilitate Alzheimer's patients.

Avastin re-submitted to FDA

Perhaps the second time is the charm for Genentech. The biotech has re-submitted a sBLA to the FDA for Avastin in combination with paclitaxel chemotherapy as a first-line treatment for metastatic

Press Release: Phase III Trial of Nexavar Does Not Meet Primary Endpoint

Press Release: Phase III Trial of Nexavar Does Not Meet Primary Endpoint

SPOTLIGHT: Synta gets fast track for cancer therapy

The FDA has granted Synta Pharmaceuticals fast-track status for its lead oncology drug candidate, STA-4783. In a recently completed, Phase IIb clinical trial in patients with Stage IV metastatic malignant melanoma, treatment with STA-4783 plus paclitaxel achieved the primary endpoint of increasing progression-free survival. Synta was a 2004 …

Press Release: Synta Pharmaceuticals gets FDA Fast Track Designation for STA-4783

Synta Pharmaceuticals gets FDA Fast Track Designation for STA-4783